Estados financieros detallados de NeurAxis, Inc. (NRXS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
NeurAxis, Inc. registró ingresos de $3.6M en el último ejercicio fiscal, con un CAGR de 5 años del 13.1%.
Márgenes de los últimos 12 meses: margen bruto 85.6%, margen operativo -144.5%, margen neto -148.0%.
Al precio actual de $6.94, NRXS presenta beneficios negativos (P/E no significativo) y un ROE del -173.28%. La capitalización bursátil es de $87M.
Cuenta de Resultados (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $1.9M | $2.7M | $2.7M | $2.5M | $2.7M | $3.6M |
| Coste de Ventas | $481089 | $467656 | $297060 | $303345 | $362002 | $562916 |
| Beneficio Bruto | $1.4M | $2.3M | $2.4M | $2.2M | $2.3M | $3.0M |
| I+D | $166798 | $203414 | $225610 | $169315 | $206107 | $493611 |
| Generales y Administrativos | $5.4M | $5.0M | $5.5M | $8.7M | $9.3M | $10.3M |
| Gastos Operativos | $5.6M | $5.2M | $5.8M | $8.8M | $9.5M | $10.8M |
| Beneficio Operativo | -$4.1M | -$3.0M | -$3.4M | -$6.7M | -$7.2M | -$7.8M |
| EBITDA | -$3.6M | -$3.0M | -$4.3M | -$9.2M | -$7.9M | -$7.7M |
| Gastos por Intereses | $75711 | $36928 | $417601 | $5.4M | $300715 | $73969 |
| Beneficio Antes de Impuestos | -$3.7M | -$3.0M | -$4.8M | -$14.6M | -$8.2M | -$7.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$3.7M | -$3.0M | -$4.8M | -$14.6M | -$8.2M | -$7.8M |
| BPA | $-0.80 | $-0.62 | $-0.57 | $-2.32 | $-1.22 | $-0.95 |
| BPA Diluido | $-0.80 | $-0.62 | $-0.78 | $-2.32 | $-1.22 | $-0.95 |
| Acciones en Circulación (Diluidas) | $5.4M | $5.4M | $8.4M | $6.3M | $6.9M | $9.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $811414 | $968127 | $1.6M | $1.9M |
| Beneficio Bruto | $675927 | $826816 | $1.4M | $1.7M |
| Beneficio Operativo | -$2.1M | -$1.7M | -$1.7M | -$2.1M |
| EBITDA | -$2.1M | -$1.7M | -$1.7M | -$2.0M |
| Beneficio Neto | -$2.1M | -$1.7M | -$1.8M | -$2.3M |
| BPA | $-0.24 | $-0.16 | $-0.18 | $-0.19 |
| BPA Diluido | $-0.24 | $-0.16 | $-0.18 | $-0.19 |
Balance (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.9M | $320858 | $253699 | $78560 | $3.7M | $5.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $311329 | $115301 | $174399 | $73167 | $244618 | $195703 |
| Inventario | $106846 | $39180 | $48133 | $21220 | $44328 | $257132 |
| Activos Corrientes | $2.5M | $491009 | $476957 | $242610 | $4.3M | $5.7M |
| Inmovilizado Material | $301705 | $245517 | $189393 | $158815 | $374638 | $337129 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $25897 | $23956 | $77558 | $108073 | $96588 | $274778 |
| Activos Totales | $2.8M | $760482 | $1.5M | $509498 | $4.8M | $6.4M |
| Cuentas por Pagar | $164558 | $483790 | $1.6M | $1.2M | $596946 | $139365 |
| Deuda a Corto | $151005 | $250407 | $489227 | $148062 | $154152 | $148293 |
| Pasivos Corrientes | $1.0M | $1.4M | $7.0M | $1.9M | $2.4M | $2.8M |
| Deuda a Largo | 0 | $51692 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.1M | $1.6M | $7.1M | $1.9M | $2.7M | $3.0M |
| Reservas | -$26.1M | -$29.2M | -$33.9M | -$48.6M | -$56.8M | -$64.6M |
| Patrimonio Neto | $1.6M | -$825660 | -$5.6M | -$1.4M | $2.1M | $3.4M |
| Deuda Total | $311492 | $439275 | $598821 | $224260 | $473405 | $416611 |
| Deuda Neta | -$1.6M | $118417 | $345122 | $145700 | -$3.2M | -$4.5M |
| Capital Circulante | $1.5M | -$933847 | -$6.5M | -$1.6M | $1.8M | $2.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $4.4M | $5.0M | $7.1M | $8.3M |
| Activos Totales | $5.8M | $6.4M | $8.7M | $10.0M |
| Pasivos Totales | $3.5M | $3.0M | $3.0M | $3.3M |
| Patrimonio Neto | $2.3M | $3.4M | $5.7M | $6.7M |
| Deuda Total | $478425 | $416611 | $353522 | $279392 |
Flujo de Caja (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$3.7M | -$3.0M | -$4.8M | -$14.6M | -$8.2M | -$7.8M |
| Amortizaciones | $35787 | $36708 | $37133 | $40725 | $37831 | $59501 |
| Compensación en Acciones | $48774 | $48641 | $27319 | $750000 | $1.4M | $596852 |
| Cambio en Capital Circulante | -$295450 | $644434 | $1.3M | -$665747 | $141398 | $610119 |
| Flujo de Caja Operativo | -$4.1M | -$2.2M | -$2.3M | -$6.7M | -$6.1M | -$6.4M |
| Inversiones (CapEx) | -$27719 | -$1390 | -$61205 | -$71781 | -$27776 | -$31150 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$4.2M | -$2.2M | -$2.4M | -$6.8M | -$6.1M | -$6.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.4M | -$1.9M | -$1.2M | -$1.0M |
| Inversiones (CapEx) | -$1 | -$5862 | -$3 | -$6303 |
| Flujo de Caja Libre | -$1.4M | -$1.9M | -$1.2M | -$1.0M |
| Dividendos Pagados | 0 | 0 | 0 | -$25 |
| Compensación en Acciones | $160316 | $157136 | $329434 | $639803 |
Crecimiento y Márgenes (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +41.0% | -1.3% | -8.4% | +9.2% | +32.9% |
| Crecimiento Beneficio Neto (anual) | | +18.7% | -57.9% | -206.0% | +43.7% | +5.4% |
| Crecimiento BPA (anual) | | +22.5% | +8.1% | -307.0% | +47.4% | +22.1% |
| Cambio en Acciones (anual) | | +0.0% | +56.3% | -25.2% | +9.9% | +31.3% |
| Crecimiento FCF (anual) | | +46.3% | -5.5% | -186.8% | +9.5% | -5.5% |
| Margen Bruto | 75.1% | 82.8% | 88.9% | 87.7% | 86.5% | 84.2% |
| Margen Operativo | -213.5% | -109.1% | -125.6% | -270.9% | -266.5% | -219.4% |
| Margen EBITDA | -187.3% | -108.6% | -161.1% | -375.1% | -294.2% | -214.8% |
| Margen Neto | -193.0% | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| Margen FCF | -215.9% | -82.2% | -87.9% | -275.0% | -228.1% | -181.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.77 | $-0.42 | $-0.28 | $-1.07 | $-0.89 | $-0.71 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $5.4M | $5.4M | $8.4M | $6.3M | $6.9M | $9.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -173.28% |
| Rentabilidad sobre capital invertido | -109.52% |
| Rentabilidad sobre activos | -78.73% |
| Margen bruto | 85.56% |
| Margen operativo | -144.51% |
| Margen neto | -148.04% |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 3.04 |
Ratios Clave (10 años)
| Año | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -7.50 | -9.68 | -10.53 | -1.15 | -1.93 | -4.78 |
| P/VC | 19.65 | -39.11 | -9.06 | -11.98 | 7.86 | 12.13 |
| P/V | 16.73 | 11.87 | 18.80 | 6.83 | 6.05 | 11.55 |
| Margen Bruto | 75.1% | 82.8% | 88.9% | 87.7% | 86.5% | 84.2% |
| Margen Operativo | -213.5% | -109.1% | -125.6% | -270.9% | -266.5% | -219.4% |
| Margen Neto | -193.0% | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |